Firas Kobaissy, PhD

American University of Beirut Profile

Dr. Kobeissy, PhD is a trained neuroscientist with an extensive experience in experimental brain injury and omics-approaches pertaining to the studies of biomarker identification. Dr. Kobeissy is an assistant Professor at the Department of Biochemistry and Molecular biology at the American University of Beirut. He obtained his PhD from the University of Florida in the area of Neuroscience. His current research is in the area of biochemistry and neuroscience focusing on identifying biomarkers drug abuse toxicity and traumatic brain injury via neuroproteomics approaches. He is a member of the Center of Neuroproteomics and Biomarker Research and the Center for Traumatic Brain Injury Studies at the McKnight Brain Institute at the University of Florida.

His experience extends to be a senior scientist at the biotech company, Banyan Biomarkers, Inc responsible for Systems Biology analysis of neurotrauama biomarkers. Several collaborative projects of Dr. Kobeissy have been funded via the NIH and DoD grants. He served for 5 years as a full member at the Department of Veteran affairs in USA, study section of Stroke and Brain Injury. Dr. Kobeissy is an expert in systems biology analysis with extensive experience in omics and high throughput data analysis; He is IPA certified (Ingenuity Center, 2011, Boston) along with experience in Pathway studio software training. Dr. Kobeissy is the author of more than 90 articles, reviews and book chapters along with two patents.

He is the editor of four books (Amazon: Springer, Elsevier, Humana Press, CRC and Taylor and Francis); these books deal with biomarker identification and proteomics research. Current research involves: studying the altered exaggerated level of bleeding after head trauma in elderly patients while they are taking the combination of both Aspirin and Clopidogrel.

In addition, Dr. Kobeissy has one study evaluating the effect of Kallikrein system in brain injury and neuronal injury via biochemical proteomics approaches. All achievements of this project will be publicly available through scientific publications and conferences for further scientific exploitation.